Have a personal or library account? Click to login
Adverse Effect in Patients with Psoriasis Treated with Interleukin 17A Inhibitor- Secukinumab Cover

Adverse Effect in Patients with Psoriasis Treated with Interleukin 17A Inhibitor- Secukinumab

Open Access
|May 2022
DOI: https://doi.org/10.2478/sjecr-2022-0013 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Submitted on: Aug 24, 2021
Accepted on: Mar 26, 2022
Published on: May 27, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Ardea Milidrag, Medo Gutić, Ivana Rodić, Ana Pjevač, Tatjana Mladenović, Vesna Miličić, Ana Ravić-Nikolić, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT